TipRanks
Advertisement
Advertisement
Vyome announces CNIPA granted patent covering formula related to besifloxacin
PremiumThe FlyVyome announces CNIPA granted patent covering formula related to besifloxacin
3M ago
Vyome reports Q1 EPS (15c) vs. ($761.59) last year
Premium
The Fly
Vyome reports Q1 EPS (15c) vs. ($761.59) last year
4M ago
Vyome signs exclusive license agreement with Impetis
Premium
The Fly
Vyome signs exclusive license agreement with Impetis
4M ago
Vyome Holdings to present Phase 2 data on VT-1953 at AACR 2026
PremiumThe FlyVyome Holdings to present Phase 2 data on VT-1953 at AACR 2026
6M ago
Vyome Holdings reports FY25 revenue $319.7k vs $246.9k last year
Premium
The Fly
Vyome Holdings reports FY25 revenue $319.7k vs $246.9k last year
6M ago
Vyome’s Livechain Acquires Humanyze to Expand AI HR Analytics
Premium
Company Announcements
Vyome’s Livechain Acquires Humanyze to Expand AI HR Analytics
7M ago
Vyome’s LiveChain Signs LOI for Humanyze Note Acquisition
PremiumCompany AnnouncementsVyome’s LiveChain Signs LOI for Humanyze Note Acquisition
9M ago
Vyome Holdings: Promising Advancements in MFW Treatment and Strategic Market Positioning Drive Buy Rating
Premium
Ratings
Vyome Holdings: Promising Advancements in MFW Treatment and Strategic Market Positioning Drive Buy Rating
9M ago
Vyome Holdings announces VT-1953 trial achieves primary, secondary endpoints
Premium
The Fly
Vyome Holdings announces VT-1953 trial achieves primary, secondary endpoints
10M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100